Cite
HARVARD Citation
Buttigliero, C. et al. (2019). Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non‐Small Cell Lung Cancer. Oncologist. pp. e251-e259. [Online].